Lykan Bioscience

📍 Hopkinton, United States🗓 Founded 2019👥 99 employees💰 Last funded Apr 2021
Biotechnology Research🌐 lykanbio.com
Website LinkedIn
Lykan Bioscience is a contract development and manufacturing services organization (CDMO) focused on cell-based therapies. With decades of biopharmaceutical industry experience, Lykan offers a full range of development and manufacturing services. The state-of-the-art, purpose-built facility offering eight independent manufacturing suites is uniquely designed to fully integrate cGMP principles and advanced software solutions to enable real-time testing and release of product. Located in Hopkinton, Massachusetts, 25 miles southwest of downtown Boston and in the proximity of three international airports, Lykan Bioscience is ideally situated to deliver life-saving cell therapy treatments to patients on behalf of their partners.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Lykan Bioscience?
Lykan Bioscience has 1 investor on record on gritt.io, including 1 early-stage backers.
When did Lykan Bioscience last raise funding?
The most recent investment in Lykan Bioscience recorded on gritt.io was in April 2021.
When was Lykan Bioscience founded?
Lykan Bioscience was founded in 2019.
What industry is Lykan Bioscience in?
Lykan Bioscience operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Lykan Bioscience based?
Lykan Bioscience is headquartered in Hopkinton, United States.